Myosin-10 also known as myosin heavy chain 10 or non-muscle myosin IIB (NM-IIB) is a protein that in humans is encoded by the MYH10gene.[1][2] Non-muscle myosins are expressed in a wide variety of tissues, but NM-IIB is the only non-muscle myosin II isoform expressed in cardiac muscle, where it localizes to adherens junctions within intercalated discs. NM-IIB is essential for normal development of cardiac muscle and for integrity of intercalated discs. Mutations in MYH10 have been identified in patients with left atrial enlargement.
NM-IIB is 228.9 kDa protein composed of 1976 amino acids.[3] NM-IIB has an N-terminal globular head that harbors the catalytically active, magnesium(Mg)-ATPase. The C-terminal rod domain is an alpha helicalcoiled-coil that can multimerize with other myosin molecules to form a filament. Bound to the neck region of NM-IIB are two light chains; first, MLC17 stabilizes the molecule, while the second light chain, MLC20, modulates contraction.[4] The exception to this rule is the alternatively spliced NM-IIB2 isoform, which has a 21 amino acid inserted into loop 2, near the actin-binding domain; actomyosin MgATPase activity of this isoform is not enhanced by phosphorylation of the regulatory light chain MLC20.[5]
NM-IIB is part of the larger myosin II subfamily of proteins, which also includes skeletal muscle, cardiac muscle and smooth musclemyosins. NM-IIB, and non-muscle myosins in general, are widely expressed in every tissue in humans.
Various functions of NM-IIB require the phosphorylation of the regulatory light chain MLC20, including cell migration and cell adhesion. The two primary kinases catalyzing this reaction are the calcium-calmodulin-dependent, myosin light chain kinase and the Rho-GTP dependent, Rho kinase (ROCK). NM-IIB is dephosphorylated by a myosin phosphatase.[7]
Detailed kinetic studies on NM-IIB show that this isoform of non-muscle myosin II has a slower actomyosin ATPase cycle relative to other myosin II isoforms, and that the markedly high affinity of NM-IIB head for ADP as well as the slow rate of ADP release can mechanistically explain affinity this finding. These data indicate that NM-IIB spends a large amount of its kinetic cycle in a configuration where it is strongly attached to actin.[8]
NM-IIB, along with the other non-muscle myosin isoforms IIA and IIC, play a role in cell-cell and cell-matrix adhesion, cell migration, cell polarity, and embryonic stem cell apoptosis.[9][10] Insights into the function of NM-IIB specifically have come from studies employing transgenic animals. NM-IIB is clearly required for normal development of cardiac muscle. Targeted gene disruption of NM-IIB resulted in approximately 65% embryonic lethality, and those that survived suffered from congestive heart failure and died day 1 following birth. Feature observed in NM-IIB knockouts was an increase in the transverse diameters of cardiomyocytes, ventricular septal defects, as well as other muscular abnormalities.[11] NM-IIB is expressed early during embryonic development in cardiomyocytes,[12] and appears to play a role in karyokinesis; ablation of NM-IIB caused defects in chromatid segregation and mitotic spindle formation, as well as abnormal structure of centrosomes.[13][14]
In adult cardiomyocytes, NM-IIB redistributes from a diffuse cytoplasmic pattern in development to a localized Z-disc and intercalated disc distribution, where it colocalizes with alpha-actinin. NM-IIB is the only non-muscle myosin II isoform expressed in adult cardiac muscle (both IIa and IIB are expressed in skeletal muscleZ-discs, suggesting a specific function of NM-IIB in this cell type.[15] NM-IIB may play a role in formation of mature sarcomeres in myofibrils.[16] It appears that NM-IIB plays an essential role in maintaining normal adherens junction integrity and structure. A cardiac muscle-specific knockout of NM-IIB using the alpha-myosin heavy chain promoter-driven cre-recombinase develop enlarged cardiomyocytes, consistent with the defects previously observed with cytokinesis; widened adherens junctions; and progressive hypertrophic cardiomyopathy at 6 months.[17] These data indicate that NM-IIB functions in ensuring the proper maintenance of intercalated disc structures.[18]
↑Simons M, Wang M, McBride OW, Kawamoto S, Yamakawa K, Gdula D, Adelstein RS, Weir L (Aug 1991). "Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes". Circulation Research. 69 (2): 530–9. doi:10.1161/01.res.69.2.530. PMID1860190.
↑Ito M, Nakano T, Erdodi F, Hartshorne DJ (Apr 2004). "Myosin phosphatase: structure, regulation and function". Molecular and Cellular Biochemistry. 259 (1–2): 197–209. doi:10.1023/b:mcbi.0000021373.14288.00. PMID15124925.
↑Wang F, Kovacs M, Hu A, Limouze J, Harvey EV, Sellers JR (Jul 2003). "Kinetic mechanism of non-muscle myosin IIB: functional adaptations for tension generation and maintenance". The Journal of Biological Chemistry. 278 (30): 27439–48. doi:10.1074/jbc.M302510200. PMID12704189.
↑Takeda K, Kishi H, Ma X, Yu ZX, Adelstein RS (Aug 2003). "Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis". Circulation Research. 93 (4): 330–7. doi:10.1161/01.RES.0000089256.00309.CB. PMID12893741.
↑Takeda K, Yu ZX, Qian S, Chin TK, Adelstein RS, Ferrans VJ (May 2000). "Nonmuscle myosin II localizes to the Z-lines and intercalated discs of cardiac muscle and to the Z-lines of skeletal muscle". Cell Motility and the Cytoskeleton. 46 (1): 59–68. doi:10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q. PMID10842333.
↑Sanger JW, Kang S, Siebrands CC, Freeman N, Du A, Wang J, Stout AL, Sanger JM (2005). "How to build a myofibril". Journal of Muscle Research and Cell Motility. 26 (6–8): 343–54. doi:10.1007/s10974-005-9016-7. PMID16465476.
Phillips CL, Yamakawa K, Adelstein RS (Aug 1995). "Cloning of the cDNA encoding human nonmuscle myosin heavy chain-B and analysis of human tissues with isoform-specific antibodies". Journal of Muscle Research and Cell Motility. 16 (4): 379–89. doi:10.1007/BF00114503. PMID7499478.
Strand D, Unger S, Corvi R, Hartenstein K, Schenkel H, Kalmes A, Merdes G, Neumann B, Krieg-Schneider F, Coy JF (Jul 1995). "A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain". Oncogene. 11 (2): 291–301. PMID7542763.
Maupin P, Phillips CL, Adelstein RS, Pollard TD (Nov 1994). "Differential localization of myosin-II isozymes in human cultured cells and blood cells". Journal of Cell Science. 107 (11): 3077–90. PMID7699007.
Itoh K, Adelstein RS (Jun 1995). "Neuronal cell expression of inserted isoforms of vertebrate nonmuscle myosin heavy chain II-B". The Journal of Biological Chemistry. 270 (24): 14533–40. doi:10.1074/jbc.270.24.14533. PMID7782316.
Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M (Dec 1993). "Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis". Circulation Research. 73 (6): 1000–12. doi:10.1161/01.res.73.6.1000. PMID7916668.
Kawamoto S (Jul 1996). "Neuron-specific alternative splicing of nonmuscle myosin II heavy chain-B pre-mRNA requires a cis-acting intron sequence". The Journal of Biological Chemistry. 271 (30): 17613–6. doi:10.1074/jbc.271.30.17613. PMID8663598.
Weir L, Chen D (1997). "Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F". Gene Expression. 6 (1): 45–57. PMID8931991.
Ford HL, Silver DL, Kachar B, Sellers JR, Zain SB (Dec 1997). "Effect of Mts1 on the structure and activity of nonmuscle myosin II". Biochemistry. 36 (51): 16321–7. doi:10.1021/bi971182l. PMID9405067.
Trinczek B, Brajenovic M, Ebneth A, Drewes G (Feb 2004). "MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes". The Journal of Biological Chemistry. 279 (7): 5915–23. doi:10.1074/jbc.M304528200. PMID14594945.
Bastian P, Lang K, Niggemann B, Zaenker KS, Entschladen F (Jan 2005). "Myosin regulation in the migration of tumor cells and leukocytes within a three-dimensional collagen matrix". Cellular and Molecular Life Sciences. 62 (1): 65–76. doi:10.1007/s00018-004-4391-6. PMID15619008.
Nakasawa T, Takahashi M, Matsuzawa F, Aikawa S, Togashi Y, Saitoh T, Yamagishi A, Yazawa M (Jan 2005). "Critical regions for assembly of vertebrate nonmuscle myosin II". Biochemistry. 44 (1): 174–83. doi:10.1021/bi048807h. PMID15628858.